Clinical Trial Update: SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the University of Pennsylvania is evaluating an SGLT2 inhibitor in combination with potassium nitrate for heart failure wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Potassium Nitrate (potassium nitrate)
• SGLT2 inhibitor (class) (SGLT2 inhibitor)

Snippet

Sponsor: University of Pennsylvania | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: RECRUITING